A study to assess the effect of Palliative care on quality of life of patients suffering from advance bronchogenic carcinoma

Ajay Kundu; Sameer Singhal; Jai Kishan; Achchhar Singh; Ajit Yadav

doi:10.53730/ijhs.v6nS3.5716

Authors

Ajay Kundu PG resident, Pulmonary Medicine, MMIMSR (deemed to be university), Mullana, Ambala, Haryana, India
Sameer Singhal Professor, Pulmonary Medicine, MMIMSR (deemed to be university), Mullana, Ambala, Haryana, India
Jai Kishan Professor & HOD, Pulmonary Medicine, MMIMSR (deemed to be university), Mullana, Ambala, Haryana, India
Achchhar Singh Associate professor, Pulmonary Medicine, MMIMSR (deemed to be university), Mullana, Ambala, Haryana, India
Ajit Yadav
ajiyadav99@gmail.com
Assistant professor, Pulmonary Medicine, MMIMSR (deemed to be university), Mullana, Ambala, Haryana, India

Keywords:

palliative care, lung cancer, QOL

Abstract

To assess the effect of Palliative care on quality of life of patients suffering from advance bronchogenic carcinoma. The present cross-sectional study was conducted in the department of respiratory medicine, M.M. Institute of Medical Sciences and Research, Mullana. Total 48 patients presented with Stage IV lung carcinoma to the department of respiratory medicine were considered for the study. After checking the inclusion and exclusion criteria, patient were enrolled in the study. Thorough detailed history was taken from all the patients and recorded on a proforma. Symptoms of the patients will be recorded. For grading of dyspnea, MMRC scale was used. Thorough physical examination was done and recorded. Radiological investigations in the form of X-ray chest and/or CT scan (whenever appropriately required was done). All these patients were then subjected to ECOG (Eastern Cooperation Oncology Group) score and EORTC LC-29 European Organisation for Research and Treatment of Cancer -Lung Cancer 29) and KP score (Karnofsky Performance Scale index) score for performance status at the time of presentation/diagnosis and receiving palliative treatment. The average age of the participants in the study was 57.39 years.

Downloads

Download data is not yet available.

References

Nath V, Grewal K S. Cancer in India. Ind J Med Res 1935;23:149-190.

KhuriFr, HerbstRs, Fossells FV. Emerging therapies in non-small-cell lung cancer. Ann Oncol2001;12:739-44.

Jemal A, Ward E, Hao Y, Tparkin DM, Bray F hun M. trends in the leading causes of death in united states, 1970 – 2002. JAMA. 2005;294(10);1255- 1259

Mattson ME,Pollack ES, Lopez, Cullen JW. What are the odds that smoking will kill you? Am J Public health. 1987;77(4):425-431.

Parkin DM ,Pisani P, Lopez AD, masuyer E. At least 1 in 7 cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer. 1994;59(4): 494-504

Parkin DM, BreyF,Ferley J, Pisani P. Global center statistics 200. CA cancer J Clin. 2005;55(2):74-108

Pass HI, Carbone DP, Johnson DH, Minna JD, Scagliotti GV, Turrisi AT3. Principles and practice of lung cancer the official reference text of the international association for the study of lung cancer (IASLC). Fourth ed. LWW 2010. 1040 p.

Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007; 11:2381- 2386.

Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014 May 17;383(9930):1721-30.

King JD, Eickhoff J, Traynor A, Campbell TC. Integrated Onco-Palliative Care Associated With Prolonged Survival Compared to Standard Care for Patients With Advanced Lung Cancer: A Retrospective Review. J Pain Symptom Manage. 2016 Jun;51(6):1027-32.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S. Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Ann Oncol. 2019 May;30(5):863-870.

Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. J Clin Oncol. 1995 May;13(5):1215-20.

Krishnasamy M, Wells M, Wilkie E. Patients and carer experiences of care provision after a diagnosis of lung cancer in Scotland. Support Care Cancer. 2007 Mar;15(3):327-32.

Naughton MJ, Herndon JE 2nd, Shumaker SA, Miller AA, Kornblith AB, Chao D, Holland J. The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res. 2002 May;11(3):235-48.

Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. Qual Life Res. 2003 Mar;12(2):157-66.

Fayers PM. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer. 2001 Jul;37(11):1331-4.

Cooley ME. Symptoms in adults with lung cancer. A systematic research review. J Pain Symptom Manage. 2000 Feb;19(2):137-53.

Stout R, Barber P, Burt P, Hopwood P, Swindell R, Hodgetts J, Lomax L. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol. 2000 Sep;56(3):323-7.

Schrier AC, Dekker FW, Kaptein AA, Dijkman JH. Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest. 1990 Oct;98(4):894-9.

Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer. 2001 Feb-Mar;31(2-3):233-40.

Osoba D, Murray N, Gelmon K, Karsai H, Knowling M, Shah A, McLaughlin M, Fetherstonhaugh E, Page R, Bowman CA. Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy. Oncology (Williston Park). 1994 Apr;8(4):61-5

Karnofsky DA, Burchenal JH. In: Evaluation of chemotherapeutic agents. MacLeod CM, editor. New York: Columbia University Press; 1949. The clinical evaluation of chemotherapeutic agents in cancer; pp. 191–205.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.

ergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer. 1994;30A(5):635-42.

Spiro SG, Gould MK, Colice GLInitial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines. Chest. 2007 Sep;132(3 Suppl):149S-160S.

Prasad R, James P, Kesarwani V, Gupta R, Pant MC, Chaturvedi A. Clinicopathological study of bronchogenic carcinoma. Respirology. 2004 Nov 1;9(4):557-60.

Bhattacharya K, Deb AR, Dastidar AG, Roy A, Saha S, Sur P. Bronchogenic carcinoma in young adults. Journal of the Indian Medical Association. 1996 Jan;94(1):18-20

Mohan A, Singh P, Kumar S, Mohan C, Pathak AK,Guleria R. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer. Asian Pac J Cancer Prevo 2008 Jan 1;9(4):557-62 .

Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D, Andreyev HJ. Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer. 2007 Jan;15(1):39-46.

Wu AH, Fontham ET, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1995;141(11):1023–1032.

Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986;105(4):503–507.

Tockman MS, Anthonisen NR, Wright EC, et al. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987;106(4):512–518.

Jindal SK, Behera D. Clinical spectrum of primary lung cancer-review of Chandigarh experience of 10 years. Lung India. 1990 May 1;8(2):94.

Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage. 2002 May;23(5):417-23.

Smith EL, Hann DM, Ahles TA, Furstenberg CT, Mitchell TA, Meyer L, Maurer LH, Rigas J, Hammond S. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage. 2001 Apr;21(4):323-9.

Moody L, McCormick K, Williams A. Disease and symptom severity, functional status, and quality of life in chronic bronchitis and emphysema (CBE). J Behav Med. 1990 Jun;13(3):297-306.

Schrier AC, Dekker FW, Kaptein AA, Dijkman JH. Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest. 1990 Oct;98(4):894-9.

Gift AG. Dyspnea. Nurs Clin North Am. 1990 Dec;25(4):955-65.

Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.

Bhutani M, Mohan A, Goyal A, Singh P, Singh S, Guleria R. Survival in small cell lung cancer in India: prognostic utility of clinical features, laboratory parameters and response to treatment. Indian journal of cancer. 2006 Apr 1;43(2):67.